Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Bu‐Nam Jeon"'
Autor:
Se‐Hoon Lee, Yeongmin Kim, Bu‐Nam Jeon, Gihyeon Kim, Jinyoung Sohn, Youngmin Yoon, Sujeong Kim, Yunjae Kim, Hyemin Kim, Hongui Cha, Na‐Eun Lee, Hyunsuk Yang, Joo‐Yeon Chung, A‐Reum Jeong, Yun Yeon Kim, Sang Gyun Kim, Yeonhee Seo, Sehhoon Park, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Hansoo Park, Kyoung Wan Yoon
Publikováno v:
Advanced Science, Vol 10, Iss 17, Pp n/a-n/a (2023)
Abstract Immune checkpoint inhibitor (ICI) clinically benefits cancer treatment. However, the ICI responses are only achieved in a subset of patients, and the underlying mechanisms of the limited response remain unclear. 160 patients with non‐small
Externí odkaz:
https://doaj.org/article/4ff970230138448ab38c9661f2b162ca
Autor:
Hye-Ran Kim, YeVin Mun, Kyung-Sik Lee, Yoo-Jin Park, Jeong-Su Park, Jin-Hwa Park, Bu-Nam Jeon, Chang-Hyun Kim, Youngsoo Jun, Young-Min Hyun, Minsoo Kim, Sang-Myeong Lee, Chul-Seung Park, Sin-Hyeog Im, Chang-Duk Jun
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-19 (2018)
Microvilli can participate in adhesion or migration of T cells, but whether they are involved in function regulation is unclear. Here the authors show that T cell microvilli form budding vesicles containing T cell signalling components for deposition
Externí odkaz:
https://doaj.org/article/157de28a8969474ca1a83eae7fbf2e7b
Autor:
Bu-Nam Jeon, Hye-Ran Kim, Yun Shin Chung, Bo-Ra Na, Hyunkyung Park, Chorong Hong, Yasmin Fatima, Hyeonju Oh, Chang-Hyun Kim, Chang-Duk Jun
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Correct temporal and spatial control of actin dynamics is essential for the cytotoxic T cell effector function against tumor cells. However, little is known whether actin engineering in tumor-targeted T cells can enhance their antitumor responses, th
Externí odkaz:
https://doaj.org/article/6daf097227694acc81269f7b0202ca5d
Autor:
Bu-Nam Jeon, Yeon-Sook Kim, Won-Il Choi, Dong-In Koh, Min-Kyeong Kim, Jae-Hyeon Yoon, Min-Young Kim, Benjamin Hur, Philip Dong-Hyun Paik, Man-Wook Hur
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 4, Pp 755-766 (2012)
Kr-pok (kidney cancer-related POZ domain and Krüppel-like protein) is a new proto-oncogenic POZ-domain transcription factor. Fatty acid synthase gene (FASN) encodes one of the key enzymes in fatty acids synthesis and is the only enzyme that synthesi
Externí odkaz:
https://doaj.org/article/a49e0058b2274290850b105633e78675
Autor:
Se‐Hoon Lee, Yeongmin Kim, Bu‐Nam Jeon, Gihyeon Kim, Jinyoung Sohn, Youngmin Yoon, Sujeong Kim, Yunjae Kim, Hyemin Kim, Hongui Cha, Na‐Eun Lee, Hyunsuk Yang, Joo‐Yeon Chung, A‐Reum Jeong, Yun Yeon Kim, Sang Gyun Kim, Yeonhee Seo, Sehhoon Park, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Hansoo Park, Kyoung Wan Yoon
Publikováno v:
Advanced Science.
Publikováno v:
Journal of Cellular Biochemistry. 123:644-656
The factor binding inducer of short transcripts-1 (FBI-1) is a POZ-domain Kruppel-like (POK) family of transcription factors and is known as a proto-oncogene or tumor suppressor in various carcinomas. However, the role of FBI-1 on epithelial-to-mesen
Autor:
Eulgi Lee, Kyungchan Min, Hyeok Ahn, Bu-nam Jeon, Shinyoung Park, Changhee Yun, Hyehee Jeon, Jae-sung Yeon, Hyun Kim, Hansoo Park
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 17; Pages: 9551
Disruption of the skin microbial balance can exacerbate certain skin diseases and affect prognosis and treatment. Changes in the distribution and prevalence of certain microbial species on the skin, such as Staphylococcus aureus (SA), can impact the
Publikováno v:
Experimental & Molecular Medicine
Zbtb7c is a proto-oncoprotein that controls the cell cycle and glucose, glutamate, and lipid metabolism. Zbtb7c expression is increased in the liver and white adipose tissues of aging or high-fat diet-fed mice. Knockout or knockdown of Zbtb7c gene ex
Autor:
Mi Young Cha, Youngeun Ha, Bu-Nam Jeon, Hyunuk Kim, Yunyeon Kim, Jiyeong Lee, Han-Sol Kim, A-Reum Jeong, Hyunkyung Yu, Kyung Mi Park, Hansoo Park
Publikováno v:
Cancer Research. 83:2968-2968
Immunotherapeutic treatment has profoundly improved the clinical outcomes in patients with advanced cancers. However, most patients still have not responded to immune checkpoint inhibitor (ICI) treatment. Thus, it is still urgent to find novel treatm
Autor:
Gwang Bin Lee, Hayung Chung, Jee Young Kwon, Youngmin Yoon, Myeong Hee Moon, Sung Yup Cho, Choa An, Hyun Young Kim, George M. Weinstock, Yeongmin Kim, Seong-Gon Kim, Hansoo Park, Mongjoo Jang, Suro Lee, Jin Ju Jeong, Yun Yeon Kim, Bu-Nam Jeon, Sang Gyun Kim, Sujeong Kim, Jinyoung Sohn, Sungho Won, Kyoung Wan Yoon, Se-Hoon Lee, Charles Lee, Hyun Yang, Sarang Kim, Myung Hee Nam, Hong Sook Kim, Gihyeon Kim, Eun Ju Lee, Yunjae Kim, Changho Park, Joon Suk Park
Publikováno v:
Nature Microbiology. 6:277-288
The gut microbiome can influence the development of tumours and the efficacy of cancer therapeutics1-5; however, the multi-omics characteristics of antitumour bacterial strains have not been fully elucidated. In this study, we integrated metagenomics